NDC 78206-161

REMERON

Mirtazapine

REMERON is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Mirtazapine.

Product ID78206-161_2df18881-af1b-4ae0-abb8-275d639749e1
NDC78206-161
Product TypeHuman Prescription Drug
Proprietary NameREMERON
Generic NameMirtazapine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-06-01
Marketing CategoryNDA /
Application NumberNDA020415
Labeler NameOrganon LLC
Substance NameMIRTAZAPINE
Active Ingredient Strength30 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 78206-161-01

1 BOTTLE in 1 CARTON (78206-161-01) > 30 TABLET, FILM COATED in 1 BOTTLE
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "REMERON" or generic name "Mirtazapine"

NDCBrand NameGeneric Name
0052-0105REMERONMIRTAZAPINE
0052-0107REMERONMIRTAZAPINE
0052-0109REMERONMIRTAZAPINE
0052-4364REMERONMIRTAZAPINE
0052-4365REMERONMIRTAZAPINE
70518-0903REMERONREMERON
70518-2176REMERONREMERON
0093-7206MirtazapineMirtazapine
0093-7207MirtazapineMirtazapine
0093-7208MirtazapineMirtazapine
0115-1653MirtazapineMirtazapine
0115-1654MirtazapineMirtazapine
0115-1656MirtazapineMirtazapine
0185-0020mirtazapinemirtazapine
0052-0106REMERONSOLTABMIRTAZAPINE
0052-0108REMERONSOLTABMIRTAZAPINE
0052-0110REMERONSOLTABMIRTAZAPINE

Trademark Results [REMERON]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REMERON
REMERON
74552154 2061796 Live/Registered
MERCK SHARP & DOHME B.V.
1994-07-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.